216 related articles for article (PubMed ID: 8286200)
1. Differential expression of myc, max and RB1 genes in human gliomas and glioma cell lines.
Hirvonen HE; Salonen R; Sandberg MM; Vuorio E; Västrik I; Kotilainen E; Kalimo H
Br J Cancer; 1994 Jan; 69(1):16-25. PubMed ID: 8286200
[TBL] [Abstract][Full Text] [Related]
2. Expression of oligodendrocytic mRNAs in glial tumors: changes associated with tumor grade and extent of neoplastic infiltration.
Landry CF; Verity MA; Cherman L; Kashima T; Black K; Yates A; Campagnoni AT
Cancer Res; 1997 Sep; 57(18):4098-104. PubMed ID: 9307299
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of c-myc, max and mxi1 in human myeloid leukemia cells during retrodifferentiation and cell death.
Meinhardt G; Hass R
Leuk Res; 1995 Oct; 19(10):699-705. PubMed ID: 7500645
[TBL] [Abstract][Full Text] [Related]
4. Expression of glial fibrillary acidic protein, vimentin, fibronectin, and N-myc oncoprotein in primary human brain tumor cell explants.
Mapstone TB; Galloway PG
Pediatr Neurosurg; 1991-1992; 17(4):169-74. PubMed ID: 1668298
[TBL] [Abstract][Full Text] [Related]
5. The N-myc oncoprotein is a transcriptional activator and associates with max and RB1 proteins.
Wenzel A; Cziepluch C; Schürmann J; Schwab M
Prog Clin Biol Res; 1994; 385():59-66. PubMed ID: 7972238
[No Abstract] [Full Text] [Related]
6. Co-expression of low molecular weight neurofilament protein and glial fibrillary acidic protein in established human glioma cell lines.
Tlhyama T; Lee VM; Trojanowski JQ
Am J Pathol; 1993 Mar; 142(3):883-92. PubMed ID: 8456947
[TBL] [Abstract][Full Text] [Related]
7. Lack of correlation between N-myc and MAX expression in neuroblastoma tumors and in cell lines: implication for N-myc-MAX complex formation.
Raschella G; Romeo A; Negroni A; Pucci S; Dominici C; Castello MA; Bevilacqua P; Felsani A; Calabretta B
Cancer Res; 1994 Apr; 54(8):2251-5. PubMed ID: 8174135
[TBL] [Abstract][Full Text] [Related]
8. myc, max, and a novel rlf-L-myc fusion protein in small-cell lung cancer.
Västrik I; Mäkelä TP; Koskinen PJ; Saksela K; Alitalo K
Princess Takamatsu Symp; 1991; 22():307-18. PubMed ID: 1668890
[TBL] [Abstract][Full Text] [Related]
9. Hemizygosity of the MAX gene locus in HL60 cells.
Ryan KM; al-Mulla F; Jamieson T; Birnie GD
Cancer Genet Cytogenet; 1998 Dec; 107(2):93-7. PubMed ID: 9844600
[TBL] [Abstract][Full Text] [Related]
10. Expression of the myc-family proto-oncogenes and related genes max and mad in synovial tissue.
Roivainen A; Pirilä L; Yli-Jama T; Laaksonen H; Toivanen P
Scand J Rheumatol; 1999; 28(5):314-8. PubMed ID: 10568429
[TBL] [Abstract][Full Text] [Related]
11. Expression of myc-family, myc-interacting, and myc-target genes during preimplantation mouse development.
Domashenko AD; Latham KE; Hatton KS
Mol Reprod Dev; 1997 May; 47(1):57-65. PubMed ID: 9110315
[TBL] [Abstract][Full Text] [Related]
12. Myc family oncoproteins function through a common pathway to transform normal cells in culture: cross-interference by Max and trans-acting dominant mutants.
Mukherjee B; Morgenbesser SD; DePinho RA
Genes Dev; 1992 Aug; 6(8):1480-92. PubMed ID: 1644290
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of c-Myc and Max genes is associated to inhibition of protein phosphatase 2A in K562 human leukemia cells.
Lerga A; Belandia B; Delgado MD; Cuadrado MA; Richard C; Ortiz JM; Martín-Perez J; León J
Biochem Biophys Res Commun; 1995 Oct; 215(3):889-95. PubMed ID: 7488057
[TBL] [Abstract][Full Text] [Related]
14. Expression of non-glial intermediate filament proteins in gliomas.
Hirato J; Nakazato Y; Ogawa A
Clin Neuropathol; 1994; 13(1):1-11. PubMed ID: 7518371
[TBL] [Abstract][Full Text] [Related]
15. Relevance of combinatorial profiles of intermediate filaments and transcription factors for glioma histogenesis.
Colin C; Virard I; Baeza N; Tchoghandjian A; Fernandez C; Bouvier C; Calisti A; Tong S; Durbec P; Figarella-Branger D
Neuropathol Appl Neurobiol; 2007 Aug; 33(4):431-9. PubMed ID: 17442061
[TBL] [Abstract][Full Text] [Related]
16. Expression, regulation, and chromosomal localization of the Max gene.
Wagner AJ; Le Beau MM; Diaz MO; Hay N
Proc Natl Acad Sci U S A; 1992 Apr; 89(7):3111-5. PubMed ID: 1557420
[TBL] [Abstract][Full Text] [Related]
17. Expression of L-myc and N-myc proto-oncogenes in human leukemias and leukemia cell lines.
Hirvonen H; Hukkanen V; Salmi TT; Mäkelä TP; Pelliniemi TT; Knuutila S; Alitalo R
Blood; 1991 Dec; 78(11):3012-20. PubMed ID: 1954386
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of myc-max-mad gene expression during hepatocyte proliferation in vivo: Differential regulation of mad family and stress-mediated induction of c-myc.
Mauleon I; Lombard MN; Muñoz-Alonso MJ; Cañelles M; Leon J
Mol Carcinog; 2004 Feb; 39(2):85-90. PubMed ID: 14750213
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of Max and role of c-Myc during erythroid and myelomonocytic differentiation of K562 cells.
Delgado MD; Lerga A; Cañelles M; Gómez-Casares MT; León J
Oncogene; 1995 Apr; 10(8):1659-65. PubMed ID: 7731722
[TBL] [Abstract][Full Text] [Related]
20. A dominant-negative mutant of Max that inhibits sequence-specific DNA binding by Myc proteins.
Billaud M; Isselbacher KJ; Bernards R
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2739-43. PubMed ID: 8464883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
